Huadong Medicine Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000011S1
CNY
42.38
-0.17 (-0.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
10,881.82
10,678.52
10,341.21
10,459.81
10,499.58
10,354.47
10,151.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
10,881.82
10,678.52
10,341.21
10,459.81
10,499.58
10,354.47
10,151.73
Raw Material Cost
7,238.13
7,323.93
6,882.70
7,247.95
7,096.71
7,139.70
6,855.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
30.22
25.92
14.61
31.04
32.50
23.05
35.19
Selling and Distribution Expenses
2,121.25
1,735.24
1,851.16
1,814.63
2,097.63
1,869.10
2,200.33
Other Expenses
42.76
46.30
43.89
25.10
30.60
23.56
37.09
Total Expenditure (Excl Depreciation)
9,817.25
9,548.12
9,187.35
9,344.64
9,532.84
9,267.47
9,461.47
Operating Profit (PBDIT) excl Other Income
1064.6
1130.4
1153.9
1115.2
966.7
1087
690.3
Other Income
60.98
28.73
83.28
30.51
33.85
41.76
176.37
Operating Profit (PBDIT)
1,383.46
1,417.03
1,414.01
1,363.56
1,214.64
1,342.82
1,076.44
Interest
30.22
25.92
14.61
31.04
32.50
23.05
35.19
Exceptional Items
0.00
0.00
0.00
0.00
0.03
-0.03
-7.14
Gross Profit (PBDT)
3,643.69
3,354.59
3,458.51
3,211.85
3,402.87
3,214.77
3,296.68
Depreciation
257.91
257.91
217.88
217.88
214.05
214.05
213.16
Profit Before Tax
1,095.33
1,133.20
1,181.52
1,114.64
968.12
1,105.69
820.95
Tax
198.87
190.97
236.05
210.94
152.39
207.94
125.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
900.12
914.71
949.78
866.31
833.61
862.41
649.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
900.12
914.71
949.78
866.31
833.61
862.41
649.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-10.77
-0.72
-18.20
8.08
-5.64
-2.17
3.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
889.34
913.98
931.58
874.39
827.97
860.25
652.85
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
23,751.92
24,059.69
23,060.05
22,041.38
21,760.29
21,955.24
21,047.61
Earnings per share (EPS)
0.51
0.52
0.54
0.49
0.48
0.49
0.37
Diluted Earnings per share
0.51
0.52
0.54
0.49
0.48
0.49
0.37
Operating Profit Margin (Excl OI)
9.78%
10.59%
10.76%
10.66%
9.21%
10.5%
6.77%
Gross Profit Margin
12.44%
13.03%
13.53%
12.74%
11.26%
12.75%
10.19%
PAT Margin
8.27%
8.57%
9.18%
8.28%
7.94%
8.33%
6.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.90% vs 3.26% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -2.70% vs -1.89% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -4.74% vs 4.33% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 16.60% vs 77.40% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Huadong Medicine Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
10,881.82
0
10,881.82
Other Operating Income
0.00
0.00
0.00
Total Operating income
10,881.82
0
10,881.82
Raw Material Cost
7,238.13
0
7,238.13
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
30.22
0
30.22
Selling and Distribution Expenses
2,121.25
0
2,121.25
Other Expenses
42.76
0.00
42.76
Total Expenditure (Excl Depreciation)
9,817.25
0
9,817.25
Operating Profit (PBDIT) excl Other Income
1,064.58
0.00
1,064.58
Other Income
60.98
0
60.98
Operating Profit (PBDIT)
1,383.46
0
1,383.46
Interest
30.22
0
30.22
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
3,643.69
0
3,643.69
Depreciation
257.91
0
257.91
Profit Before Tax
1,095.33
0
1,095.33
Tax
198.87
0
198.87
Provisions and contingencies
0
0
0.00
Profit After Tax
900.12
0
900.12
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
900.12
0
900.12
Share in Profit of Associates
0
0
0.00
Minority Interest
-10.77
0
-10.77
Other related items
0.00
0.00
0.00
Consolidated Net Profit
889.34
0
889.34
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
23,751.92
0
23,751.92
Earnings per share (EPS)
0.51
0
0.51
Diluted Earnings per share
0.51
0
0.51
Operating Profit Margin (Excl OI)
9.78%
0%
0.00
9.78%
Gross Profit Margin
12.44%
0%
0.00
12.44%
PAT Margin
8.27%
0%
0.00
8.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,088.18 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 1.90% vs 3.26% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 3.64% vs 2.76% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 88.93 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -2.70% vs -1.89% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 7.40% vs 21.78% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 132.25 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -4.74% vs 4.33% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.00% vs 5.29% in Jun 2024

Quarterly - Interest
Interest 3.02 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 16.60% vs 77.40% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -7.08% vs 55.50% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.78%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024